These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10732856)

  • 21. Relearning the lessons of history: anorexigens and pulmonary hypertension.
    Langleben D
    Chest; 1998 Jul; 114(1 Suppl):55S-57S. PubMed ID: 9676629
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of pulmonary aneurysm in primary pulmonary hypertension: a case report.
    Nienaber CA; Spielmann RP; Montz R; Bleifeld W; Mathey DG
    Angiology; 1986 Apr; 37(4):319-24. PubMed ID: 3717697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension.
    Tuder RM; Radisavljevic Z; Shroyer KR; Polak JM; Voelkel NF
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1999-2001. PubMed ID: 9847298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of the treatment of obesity by drugs: a review.
    Munro JF
    Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appetite-suppressant drugs and the risk of primary pulmonary hypertension?
    Deitel M
    Obes Surg; 1997 Feb; 7(1):3-4. PubMed ID: 9730529
    [No Abstract]   [Full Text] [Related]  

  • 27. Aminorex to fen/phen: an epidemic foretold.
    Fishman AP
    Circulation; 1999 Jan 5-12; 99(1):156-61. PubMed ID: 9884392
    [No Abstract]   [Full Text] [Related]  

  • 28. High performance liquid chromatographic determination of mazindol in human plasma.
    Kaddoumi A; Mori M; Nanashima K; Kono M; Nakashima K
    Analyst; 2001 Nov; 126(11):1963-8. PubMed ID: 11763075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium.
    Delcroix M; Kurz X; Walckiers D; Demedts M; Naeije R
    Eur Respir J; 1998 Aug; 12(2):271-6. PubMed ID: 9727773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
    Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
    Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anorectics and pulmonary hypertension].
    Bíbová J; Hampl V
    Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-induced primary vascular pulmonary hypertension. Contribution to its etiology and clinical course].
    Schnabel KH; Schulz V; Busch S; Just H
    Med Welt; 1976 Jun; 27(26):1300-3. PubMed ID: 933821
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: The epidemic of primary pulmonary hypertension in Europe.
    Lüthy E
    Pathol Microbiol (Basel); 1975; 43(2-O):246-7. PubMed ID: 1228586
    [No Abstract]   [Full Text] [Related]  

  • 35. Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis.
    Leeb BF; Scheinecker C; Schweitzer H; Smolen JS
    Br J Rheumatol; 1998 May; 37(5):586-7. PubMed ID: 9651097
    [No Abstract]   [Full Text] [Related]  

  • 36. A century of pulmonary hemodynamics.
    Fishman AP
    Am J Respir Crit Care Med; 2004 Jul; 170(2):109-13. PubMed ID: 15242851
    [No Abstract]   [Full Text] [Related]  

  • 37. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis.
    Eddahibi S; Adnot S
    Respir Res; 2002; 3(1):9. PubMed ID: 11806844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semen-like urethral discharge during the use of mazindol.
    van Puijenbroek EP; Meyboom RH
    Int J Eat Disord; 1998 Jul; 24(1):111-3. PubMed ID: 9589318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Appetite suppressants and primary pulmonary hypertension in the United Kingdom.
    Thomas SH; Butt AY; Corris PA; Egan JJ; Higenbottam TW; Madden BP; Waller PC
    Br Heart J; 1995 Dec; 74(6):660-3. PubMed ID: 8541174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mazindol administration improved hyperphagia after surgery for craniopharyngioma--case report.
    Sadatomo T; Sakoda K; Yamanaka M; Kutsuna M; Kurisu K
    Neurol Med Chir (Tokyo); 2001 Apr; 41(4):210-2. PubMed ID: 11381681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.